David Weill, Director at TransMedics Group, Inc. (TMDX), sold 3,571 shares at $146.82 ($524K) on 2026-03-04, disclosed to the SEC on 2026-03-06.
Open-market sale of $524k TMDX by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| TMDX | SELL | 2025-05-23 | $181K | — | Filing → |
| TMDX | SELL | 2024-05-31 | $338K | — | Filing → |
| TMDX | SELL | 2024-05-14 | $325K | — | Filing → |